Turn Inclusive Research Into Predictable Performance.
Acclinate combines representative data, predictive intelligence, and culturally relevant engagement to reduce trial risk, meet regulatory expectations, and accelerate enrollment timelines.
.webp)
Built for Pharma’s New Reality
Pharmaceutical teams face increasing regulatory expectations, rising enrollment costs, and growing pressure to deliver representative clinical trial data.
Acclinate helps sponsors meet these challenges by combining trusted community engagement, behavioral intelligence, and scalable recruitment infrastructure that accelerates enrollment and informs better trial design.
Strengthen Enrollment Performance
Identify representation gaps early and activate trusted community pipelines that accelerate recruitment and reduce enrollment delays across therapeutic areas.
Engage Patients With Confidence
Deliver compliant, education-first engagement programs that build trust with diverse populations while generating behavioral insights that inform both clinical development and future commercialization.
Design Studies Around Real Patient Experience
Capture real-world sentiment, barriers, and motivations directly from community members to inform protocol design, study feasibility, and patient-centered research strategies.
Activate Trusted Community Networks
Work alongside trusted organizations and local leaders to expand outreach, strengthen credibility, and create sustainable pathways between communities and clinical research.
.webp)
Solutions for Pharmaceutical Sponsors
Trusted Community Access
Connect with one of the most engaged health communities through NOWINCLUDED, enabling sponsors to reach diverse populations with trusted education and research participation opportunities.
Predictive Enrollment Intelligence
Use e-DICT to identify representation gaps, understand community sentiment, and predict enrollment performance before recruitment challenges impact trial timelines.
Culturally Relevant Patient Engagement
Deploy education-first engagement strategies that build trust with historically under represented populations and increase participation in clinical research.
Actionable Community Insights
Transform real-world community engagement into insights that inform protocol design, recruitment strategies, and future commercialization decisions.
De-Risking the Pipeline
How Pharma Teams Improve Clinical Trial Diversity, Recruitment, and Trust
How does Acclinate help improve diversity in clinical trials?
Acclinate helps sponsors reach communities historically underrepresented in research through NOWINCLUDED, a trusted community platform built through culturally relevant engagement, education, and partnerships. By combining community relationships, behavioral insights, and tech enabled engagement, sponsors can identify and connect with individuals who are informed, interested, and ready to participate in research.
How is NOWINCLUDED different from traditional patient recruitment vendors?
Traditional recruitment approaches focus primarily on advertising and site referrals. NOWINCLUDED focuses on trust and sustained engagement. Our community members are engaged through health education, cultural partnerships, and ongoing dialogue long before trial recruitment begins. This approach improves awareness, readiness, and participation while reducing recruitment friction.
Can Acclinate help reduce clinical trial enrollment risk?
Yes. Enrollment delays and lack of representative participation are major risks in clinical development. Acclinate reduces these risks by providing early insights into community attitudes, barriers to participation, and engagement readiness. Sponsors can use these insights to design more effective recruitment strategies before enrollment challenges arise.
What types of insights can pharma teams gain from Acclinate’s platform?
Through Acclinate’s analytics and community engagement infrastructure, sponsors can access insights such as community health attitudes, research awareness levels, barriers to participation, cultural considerations, and behavioral engagement patterns. These insights help inform protocol design, outreach strategy, and site engagement planning.
At what stage of clinical development should sponsors engage Acclinate?
Acclinate can support sponsors across the research lifecycle, including early protocol planning, feasibility assessments, site activation support, and recruitment engagement. Engaging early in the development process allows sponsors to better understand community perspectives and build awareness before recruitment begins.
How does community engagement impact clinical trial timelines and cost?
Clinical trial delays are often driven by slow enrollment and lack of representative participation. Community engagement helps address these challenges by building awareness, trust, and research readiness before recruitment begins. When individuals already understand clinical research and trust the organizations involved, they are more likely to consider participation. This can lead to faster enrollment, improved retention, and fewer costly recruitment adjustments during a study.
.webp)
.webp)
Stop Risking Your Pipeline Success.
Our platform delivers the certainty and compliance your executive team requires.